Insider Transactions in Q2 2022 at Amphastar Pharmaceuticals, Inc. (AMPH)
Insider Transaction List (Q2 2022)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 30
2022
|
Diane G. Gerst |
SELL
Open market or private sale
|
Direct |
5,146
-28.61%
|
$180,110
$35.0 P/Share
|
Jun 30
2022
|
Diane G. Gerst |
BUY
Exercise of conversion of derivative security
|
Direct |
5,146
+13.12%
|
$102,920
$20.06 P/Share
|
Jun 30
2022
|
William J Peters CFO, EVP & TREASURER |
SELL
Open market or private sale
|
Direct |
18,386
-15.47%
|
$625,124
$34.95 P/Share
|
Jun 30
2022
|
William J Peters CFO, EVP & TREASURER |
BUY
Exercise of conversion of derivative security
|
Direct |
18,386
+13.4%
|
$257,404
$14.95 P/Share
|
Jun 17
2022
|
William J Peters CFO, EVP & TREASURER |
SELL
Open market or private sale
|
Direct |
5,512
-5.2%
|
$176,384
$32.05 P/Share
|
Jun 14
2022
|
Yakob Liawatidewi EVP CORP ADMIN CENTER |
SELL
Payment of exercise price or tax liability
|
Direct |
128
-0.21%
|
$3,968
$31.02 P/Share
|
Jun 10
2022
|
Gayle Deflin |
BUY
Grant, award, or other acquisition
|
Direct |
4,163
+29.02%
|
-
|
Jun 10
2022
|
Diane G. Gerst |
BUY
Grant, award, or other acquisition
|
Direct |
4,163
+24.48%
|
-
|
Jun 10
2022
|
Howard Lee |
BUY
Grant, award, or other acquisition
|
Direct |
4,163
+2.83%
|
-
|
Jun 10
2022
|
Floyd F. Petersen |
BUY
Grant, award, or other acquisition
|
Direct |
4,163
+4.42%
|
-
|
Jun 10
2022
|
Richard K Prins |
BUY
Grant, award, or other acquisition
|
Direct |
4,163
+8.08%
|
-
|
Jun 10
2022
|
Michael A Zasloff |
BUY
Grant, award, or other acquisition
|
Direct |
4,163
+7.5%
|
-
|
Jun 06
2022
|
Howard Lee |
SELL
Open market or private sale
|
Direct |
10,291
-6.9%
|
$380,767
$37.79 P/Share
|
Jun 06
2022
|
Howard Lee |
BUY
Exercise of conversion of derivative security
|
Direct |
10,291
+6.46%
|
$174,947
$17.11 P/Share
|
Jun 04
2022
|
Yakob Liawatidewi EVP CORP ADMIN CENTER |
SELL
Payment of exercise price or tax liability
|
Direct |
264
-0.43%
|
$9,768
$37.77 P/Share
|
Jun 01
2022
|
Floyd F. Petersen |
SELL
Open market or private sale
|
Direct |
500
-0.29%
|
$18,500
$37.23 P/Share
|
May 23
2022
|
Howard Lee |
SELL
Open market or private sale
|
Direct |
10,000
-6.72%
|
$340,000
$34.93 P/Share
|
May 23
2022
|
Howard Lee |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+6.3%
|
$170,000
$17.11 P/Share
|
May 20
2022
|
Jack Y. Zhang CEO & CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
10,650
-0.5%
|
$362,100
$34.21 P/Share
|
May 19
2022
|
William J Peters CFO, EVP & TREASURER |
SELL
Payment of exercise price or tax liability
|
Direct |
378
-0.36%
|
$12,474
$33.7 P/Share
|
May 19
2022
|
Jack Y. Zhang CEO & CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
41,730
-0.97%
|
$1,418,820
$34.02 P/Share
|
May 18
2022
|
Jack Y. Zhang CEO & CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
67,046
-1.01%
|
$2,279,564
$34.84 P/Share
|
May 18
2022
|
Floyd F. Petersen |
SELL
Open market or private sale
|
Direct |
9,924
-10.3%
|
$347,340
$35.05 P/Share
|
May 18
2022
|
Floyd F. Petersen |
BUY
Exercise of conversion of derivative security
|
Direct |
20,291
+17.39%
|
$344,947
$17.11 P/Share
|
May 17
2022
|
Richard K Prins |
SELL
Bona fide gift
|
Direct |
2,000
-4.43%
|
-
|
May 17
2022
|
Jack Y. Zhang CEO & CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
50,376
-1.11%
|
$1,763,160
$35.94 P/Share
|
May 16
2022
|
Jack Y. Zhang CEO & CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
68,069
-1.46%
|
$2,382,415
$36.0 P/Share
|
May 16
2022
|
Michael A Zasloff |
SELL
Open market or private sale
|
Direct |
10,291
-17.9%
|
$360,185
$35.61 P/Share
|
May 16
2022
|
Michael A Zasloff |
BUY
Exercise of conversion of derivative security
|
Direct |
10,291
+15.18%
|
$174,947
$17.11 P/Share
|
May 02
2022
|
Floyd F. Petersen |
SELL
Open market or private sale
|
Direct |
295
-0.19%
|
$10,325
$35.34 P/Share
|
Apr 01
2022
|
Floyd F. Petersen |
SELL
Open market or private sale
|
Direct |
500
-0.33%
|
$18,000
$36.97 P/Share
|